- Chrissy Metz has become a new brand ambassador for telehealth company Ro, revealing for the first time that she's using a GLP-1 medication.
- The 45-year-old "This Is Us" star was skeptical of GLP-1s for roughly six years before starting treatment, citing perimenopause and a family history of obesity.
- Metz says the medication has quieted her "food noise" and eased joint pain and inflammation, helping her keep up with eight shows a week during her Broadway debut in "& Juliet."
- She joins Ro's celebrity ambassador roster alongside Serena Williams and Charles Barkley, both of whom have fronted national GLP-1 campaigns for the company.
Chrissy Metz is opening up about a major life change, and she’s doing it as the newest face of Ro.
The “This Is Us” actress, 45, revealed this week that she started taking a GLP-1 medication after years of resistance, and she’s now partnering with the telehealth company as a brand ambassador to share her story.
“I’m not getting any younger,” Metz said, pointing to perimenopause and a family history of obesity, including her father’s struggles, as reasons she finally decided to try treatment.
Metz said she’d been skeptical of GLP-1s for about six years, dating back to early COVID-era chatter about the drugs. A friend’s research, plus a hard look at her own family health history, changed her mind.
Since starting, she says the medication has quieted “food noise,” eased inflammation and joint pain, and freed up mental space for creativity, something she’s leaning on eight times a week in her Broadway debut as Angélique in “& Juliet,” the Max Martin jukebox musical currently running at the Stephen Sondheim Theatre through September 13.
“It’s helped with just overall health lab work and blood work,” Metz said, “and just generally an overall feeling of space and creativity that the food noise has quieted.”
Metz becomes Ro’s latest celebrity patient ambassador, joining a roster that includes tennis great Serena Williams, who signed on in August 2025 and starred in Ro’s first-ever Super Bowl commercial this past January, and NBA Hall of Famer Charles Barkley, who partnered with the brand in April 2025 to restart his own weight-loss journey.
Ro isn’t the only wellness brand leaning on candid patient stories this year: Thorne turned to Misty Copeland and Lana Condor for a campaign tackling perimenopause and libido, while Unisom tapped comedian Heather McMahan to front its new drug-free Sleep Support Gummies.
The Ro deal marks Metz’s first major national health-brand ambassador role, adding to a career that includes her Emmy- and Golden Globe-nominated run on “This Is Us,” film roles in “Breakthrough” and “Sierra Burgess Is a Loser,” and her current part on Netflix’s “The Hunting Wives.”
Takeaways
This isn’t a celebrity casually mentioning a weight-loss drug in passing; it’s a formal, paid ambassador role, and it arrives as Ro builds out a growing bench of “celebrity patient” faces to normalize GLP-1 use across different demographics, careers, and body-image narratives.
The timing is notable, too. Metz is speaking out mid-Broadway run, tying her GLP-1 story directly to physical stamina for eight shows a week; a concrete, relatable stake that reads differently than Williams’ athletic-comeback narrative or Barkley’s “second chance” framing.
Does hearing Metz, long known for pushing back on body-image stereotypes, discuss GLP-1 use complicate or reinforce her standing as a body-positivity figure?
Will more performers in physically demanding stage or touring roles start citing GLP-1s as a stamina and performance tool, rather than a purely cosmetic one? With Williams, Barkley, and now Metz all sharing personal GLP-1 stories for pay, how should audiences weigh authenticity against the fact that these are paid brand partnerships?
